Litcius/Paper detail

Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis

Mingnan Cao, Chen Pan, Yue Tian, Li Wang, Zhigang Zhao, Bin Zhu

2023International Journal of Clinical Pharmacy17 citationsDOI

Topics & Concepts

PharmacovigilanceMedicineAdverse Event Reporting SystemAdverse effectPharmacyPharmacologyEvent (particle physics)OncologyInternal medicineFamily medicineQuantum mechanicsPhysicsPharmacovigilance and Adverse Drug ReactionsPancreatitis Pathology and TreatmentDiabetes Treatment and Management
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis | Litcius